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three current models (transphosphorylation, lipid raft, and our preferential protein tyrosine kinase–
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Activation of mast cells and basophils through the high-afﬁnity
IgE receptor (FceRI) leads to the release of pro-inﬂammatory medi-
ators involved in inﬂammation and allergy disorders [1]. FceRI,
which belongs to the multichain immune recognition receptor
(MIRR) family is a tetrameric complex formed by an IgE-binding
a-subunit, a signal-amplifying b-subunit, and a homodimer of
disulphide-linked c-subunits. Each FceRI b- and c-subunit contains
one immunoreceptor tyrosine-based activation motif (ITAM)
which, after tyrosine phosphorylation, serves as a docking site for
other signaling molecules such as Src homology 2 (SH2) domain-
containing Src family kinase Lyn or Syk/Zap family kinase Syk
[1]. Several models have been proposed to explain mechanistically
how the FceRI becomes phosphorylated by protein tyrosine kinasechemical Societies. Published by E
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62214.(PTK) Lyn. The models differ in their perception of the spatiotem-
poral relationship between Lyn kinase and FceRI, and of the role
of protein tyrosine phosphatases (PTPs) at initial tyrosine phos-
phorylation of the receptor.
2. Models of FceRI phosphorylation
2.1. Transphosphorylation model
This model assumes that FceRI in quiescent cells is non-cova-
lently associated through its non-phosphorylated b subunit with
Lyn kinase which is unable to phosphorylate its carrier receptor
(Fig. 1). Aggregation of the IgE–FceRI complexes with multivalent
antigen initiates Lyn-dependent phosphorylation of the neighbor-
ing receptors within the aggregate [2]. This process is known as
transphosphorylation and was suggested to play a role in the signal
transduction in several other systems [3]. It is corroborated by sev-
eral experimental ﬁndings. First, when biochemically crosslinked,
at least 3–4% of the non-aggregated FceRI was found to be directly
associated with Lyn [4]. Second, Vonakis et al. [5] showed that Lyn
binds through its unique domain to b subunit of FceRI, irrespective
of phosphorylation of the ITAM. This binding does not involve Lyn
SH2 domain which interacts with phosphorylated ITAM, serving to
amplify the initial activation signal. Third, transfection of Lyn un-
ique domain into rat basophilic leukemia (RBL) cells inhibited anti-
gen-induced phosphorylation of FceRI b and c subunit; thislsevier B.V. All rights reserved.
Fig. 1. Models of FceRI phosphorylation. Transphosphorylation model presumes that active Lyn is constitutively associated with non-phosphorylated FceRI; upon FceRI
aggregation, Lyn phosphorylates adjacent receptors in the aggregate. Lipid raft model postulates that FceRI and Lyn are localized in different plasma membrane
microdomains; after aggregation FceRI is translocated to lipid rafts where it is phosphorylated by lipid raft-associated Lyn kinase. PTK–PTP interplay model assumes that PTPs
set the threshold of FceRI tyrosine phosphorylation; after FceRI triggering there is a shift in the PTK–PTP steady state in favor of PTKs.
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nous Lyn and the transfected Lyn unique domain [6]. Fourth, stud-
ies with Chinese hamster ovary ﬁbroblasts expressing FceRI and
various amounts of Lyn showed a direct correlation between
amount of Lyn and tyrosine phosphorylation of the FceRI. Detailed
mathematic analysis demonstrated that one Lyn molecule is capa-
ble of phosphorylating numerous adjacent FceRIs [7]. Fifth, Lyn
was found to colocalize with FceRI as detected by transmission
electron microscopy on plasma membrane sheets isolated from
RBL cells. In non-stimulated cells about 25% of randomly dispersed
FceRI was associated with one or a few Lyn molecules [8]. Sixth,
Lyn kinase in quiescent mast cells is enzymatically active and its
activity is not further enhanced after FceRI triggering [9]. A muta-
tion of the C terminal tyrosine, responsible for inhibition of Lyn
kinase activity, led to a weak constitutive tyrosine phosphorylation
of several substrates including b and c subunits of FceRI and Syk
kinase in non-stimulated cells [9]. Seventh, aggregation of FceRI
with trivalent ligands bound in deﬁned distance to a symmetricDNA scaffold, resulted in phosphorylation of the FceRI b and c
subunits depending on the length of DNA spacer; more potent
trivalent ligands were those with shorter spacer [10]. Similarly, it
has been suggested that dominant factor affecting signaling capac-
ity of various anti-FceRI monoclonal antibodies is the orientational
element [11]. Eight, simultaneous observation of FceRI marked
with various quantum dot-labeled IgE revealed that aggregates of
at least three crosslinked FceRI remained mobile, showed pro-
longed diffussion and exhibited phosphorylation of the FceRI b
subunit and b-glucuronidase release [12]. Finally, ﬂuorescence cor-
relation spectroscopy of Lyn-enhanced green ﬂuorescent protein
(EGFP) and ﬂuorescently labeled IgE bound to FceRI conﬁrmed that
a small fraction of FceRI in non-activated cells colocalized with Lyn
[13]. Taken together, the results from the studies applying different
methods provide a strong support for the hypothesis that a fraction
of Lyn binds to unphosphorylated FceRI, and strengthen the notion
that transphosphorylation could be the ﬁrst step in FceRI signaling.
However, some data are in conﬂict with this hypothesis. For exam-
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absence of b subunit [14]. Furthermore, chimeric receptors con-
taining only the c cytoplasmic tail become tyrosine phosphory-
lated upon their aggregation [15]. Alternative models had been
therefore proposed.
2.2. Lipid raft model
Lipid raft membrane microdomains were conceived as a mech-
anism for intracellular trafﬁcking of lipids and lipid-anchored pro-
teins. The model assumes that biological membranes possess
microdomains having a lipidic structure with properties of lipid or-
der phase. These domains are rich in cholesterol and sphingomye-
lin, and possess a limited set of proteins, including those anchored
to the membrane via glycolipids (e.g. glycophosphatidylinositol) or
acyl groups (e.g. palmitoyl or myristoyl), and also some acylated
proteins with transmembrane domain. They are surrounded by
membranes with lipid structure resembling lipid disorder phase
possessing phosphatidylinositols and a majority of the transmem-
brane proteins [16]. Cholesterol plays a crucial role in the forma-
tion of lipid rafts, and cholesterol-depletion experiments have
been used in lipid raft function studies. Membrane domains with
properties of lipid rafts are often isolated as membranes resistant
to solubilization with non-ionic detergents, such as Triton X-100
at low temperature. Thus, the lipid raft hypothesis is in part based
on studies presuming that detergent-resistant membranes (DRMs)
correspond to lipid rafts, an assumption which is probably incor-
rect [16]. On the other hand, the lipid raft model is supported by
experiments showing that aggregation of FceRI and some other
membrane proteins leads to a decreased detergent solubility as
can be documented by density gradient ultracentrifugation. From
the FceRI perspective, lipid raft model postulates that in quiescent
cells FceRI is physically separated from active Lyn residing in lipid
raft domains [17]. After aggregation, FceRI is translocated into
these domains and is phosphorylated there by Lyn (Fig. 1). De-
creased detergent solubility was observed not just in extensively
aggregated FceRI, but even upon FceRI dimerization, although the
activation was delayed and more sustained [18]. Furthermore, it
has been shown that cholesterol depletion with methyl-b-cyclo-
dextrin (MBCD) reduced phosphorylation of the FceRI subunits as
well as other proteins. The tyrosine phosphorylation of FceRI was
rescued when cholesterol was added [19]. These data were taken
as evidence that FceRI cannot be phosphorylated in the cells in
which lipid rafts are destroyed. Removal of cholesterol with MBCD,
however, led to a decreased expression of FceRI and had some12
5
Fig. 2. Phosphorylation of FceRI does not require its translocation into lipid rafts. (A) Ig
pervanadate (Pv) or antigen (Ag). The cells were solubilized and the FceRI complexes w
speciﬁc for phosphotyrosine (PY20) or FceRI b chain (loading control). Positions of FceRI
cells were sensitized with 125I-IgE and then left non-activated (C; ﬁlled squares) or activa
the cells were solubilized and fractionated by sucrose density gradient ultracentrifugatio
of the total radioactivity recovered. Percentage of sucrose in individual fractions is alsoother effects on mast cell physiology [20]; therefore, these experi-
ments cannot simply be interpreted as supporting the role of lipid
rafts in FceRI signaling.
Recent studies based on advanced microscopy methods re-
vealed that membrane domains in quiescent cells are highly dy-
namic and small in size (less than 10 nm). They can transiently
coalesce after ligand-induced aggregation of membrane proteins
and form larger domains [21]. In antigen-stimulated mast cells,
transient increase of FceRI in specialized cholesterol-rich domains,
peaking at 5 min after receptor aggregation has been described
[22]. However, it remains to be determined whether these changes
reﬂect either an association of FceRI with cholesterol-enriched li-
pid rafts possessing sequestered Lyn, or rather changes leading to
removal of aggregated FceRI. In fact, experiments with N-palmitoy-
lation-site deﬁcient Lyn show that anchor of the Lyn to the plasma
membrane but not to DRMs is important for proper tyrosine phos-
phorylation of the FceRI [23]. Furthermore, Lyn-EGFP mobility
within the plasma membrane decreased upon FceRI triggering,
and association of the kinase with FceRI was increased. However,
no change in association of aggregated FceRI with EGFP anchored
to the plasma membrane through Lyn acylation site was observed
[13]. Thus, lipid raft localization of Lyn is not sufﬁcient for its inter-
action with aggregated FceRI.
2.3. PTK–PTP interplay model
The key player in the transphosphorylation and lipid raft mod-
els in antigen-activated mast cells is the PTK Lyn utilizing FceRI
ITAM as a substrate. However, the extent of phosphorylation of
the immunoreceptors and other substrates depends not only on
enzymatic activity of the PTKs, but, at least partly, also on the
activity of PTPs. As an attempt to explain some conﬂicting experi-
mental data which were inconsistent with lipid raft model, the
PTK–PTP interplay model was coined (Fig. 1). Initially, the model
was elaborated in studies of immunoreceptor signaling in B cells.
Reth and co-workers [24] showed that the B cell receptor, belong-
ing to the MIRR family, forms a complex with PTKs and PTPs; this
complex is indispensable for reactive oxygen species (ROS)-in-
duced phosphorylation. Also, ROS encompassing superoxide or
hydrogen peroxide are known inhibitors of PTPs and are capable
of initiating early FceRI-induced signaling events in mast cells. De-
spite a growing list of conﬁrmed PTPs present in mast cells, their
contribution to cell signaling regulation is still poorly understood
[25,26]. One possible way of regulation of the PTP activity is revers-
ible oxidation of Cys residue in a conserved signature motif (I/0 5 10 15 20 25
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the signature motif makes it possible for an invariant Cys to form a
thiolate anion at physiological pH (pKa <6.0) that can act in nucle-
ophilic attack on the phosphate group. However, the same Cys res-
idue can be oxidized by ROS to catalytically inactive Cys-sulphenic
acid, a mechanism that is fully reversible by action of glutathione
or other thiols [27]. ROS are produced under physiological condi-
tions by the activity of specialized enzymes such as nicotinamide
adenine dinucleotide phosphate (NADPH)-oxidase [28,29]. Strong
oxidants like pervanadate (a mixture of vanadate and H2O2) irre-
versibly inactivate PTPs by the formation of Cys-sulphonic acid
residues [30]. Exposure of mast cells to pervanadate leads to acti-
vation events which resemble those induced by physiological
activators [31,32].Fig. 3. Membrane topography of phosphatases, actin and FceRI. Plasma membrane sheets
E, and F) or antigen-activated (Ag; D) BMMCs and after two-step labeling procedure were
gold; A and B) or from cytoplasmic side using anti-FceRI b chain (12 nm gold; F). Oxidized
and B) or 12 nm gold particles (C–E). F-Actin or SHP-2 were labeled with phalloidin (5 nm
6 nm are indicated by arrowheads and those of 12 nm by arrows. Inlets in A and B showThe PTK–PTP interplay model is supported by several lines of
evidence. First, exposure of RBL or bone marrow-derived mast cells
(BMMCs) to pervanadate or H2O2 induced robust tyrosine phos-
phorylation of the FceRI subunits in the absence of receptor migra-
tion into DRMs, as determined by solubilization of the cells in
Triton X-100 followed by sucrose density gradient ultracentrifuga-
tion. This was in sharp contrast to antigen- or anti-IgE antibody-in-
duced activation which led to the movement of FceRI into DRMs
(Fig. 2). Such data indicate that association of FceRI with DRMs is
not required for receptor phosphorylation. Second, electron
microscopy studies on isolated plasma membrane sheets showed
that FceRI in pervanadate-activated cells was distributed in the
same way as the receptor in non-activated cells. Thus, enhanced
receptor clustering is not required for tyrosine phosphorylationwere prepared from non-activated (Control; A and C), pervanadate-activated (Pv; B,
analyzed by electron microscopy. FceRI was labeled extracellularly using IgE (12 nm
phosphatases were labeled with oxPTP monoclonal antibody marked with 6 nm (A
gold; C–E) or anti-SHP-2 antibody (6 nm gold; F), respectively. Gold particles of 5–
higher magniﬁcation. Experimental procedure details have been described [32].
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ing oxidized Cys residue in catalytic domain of PTPs, enzymatically
inactive PTPs were detectable in a time- and dose-dependent man-
ner in cells activated with pervanadate, H2O2 or antigen [32].
Fourth, most of PTK substrates are not phosphorylated if pervana-
date is added to cell lysates instead of intact cells [24]. Similarly,
lysates prepared from non-activated mast cells and treated with
H2O2 or pervanadate exhibited a lower amount of oxidized PTPs
than lysates prepared from cells activated with H2O2 or pervana-
date before lysis [32]. These data suggest that solubilization of
the cells with detergents destroys preformed signaling assemblies
containing PTKs, PTPs, and their substrates. Fifth, pretreatment of
activated cells with saponine, leading to cell permeabilization
and release of the majority of free cytoplasmic components, re-
sulted in association of the majority of oxidized PTPs with cellularFig. 4. Topography of oxidized phosphatases and transmembrane adaptor proteins. Plasm
activated (Ag; C and D) and pervanadate-activated (Pv; E and F) BMMCs and labeled for o
12 nm gold. Gold particles of 6 or 12 nm in size are indicated with arrowheads or arrows
details have been described [32,38].ghosts [32]. This indicates that oxidized PTPs are not freely moving
in cytosol, but rather form large complexes. In fact, FceRI on plas-
ma membrane sheets isolated from non-activated (Fig. 3A) or acti-
vated (Fig. 3B) cells occasionally colocalizes with oxidized PTPs.
Interestingly, fraction of oxidized PTPs was associated with
membrane-bound actin cytoskeleton, especially after activation
(Fig. 3C–E). Finally, activation of the cells with antigen leads to de-
creased enzymatic activity of HePTP (PTPN7) and some other PTPs,
and exposure of the cells to H2O2 leads to a substantial decrease in
overall phosphatase activity [32].
An important task is the identiﬁcation of PTPs directly involved
in regulating the tyrosine phosphorylation of the receptor. Using a
modiﬁed immunoprecipitation procedure with oxPTP antibody,
followed by mass spectrometry analysis of the immunoprecipi-
tated proteins, we found that several PTPs are oxidized in activateda membrane sheets were prepared from non-activated (Control; A and B), antigen-
xidized PTPs with 6 nm gold (A–F) or for LAT (A, C, and E) or NTAL (B, D, and F) with
, respectively. Inlets in E and F show higher magniﬁcation. Experimental procedure
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MEG2 (PTPN9) and HePTP. However, we failed to co-immunopre-
cipitate the PTPs with FceRI and we found no binding motifs in
FceRI b and c subunits for the phosphatases, except for the phos-
photyrosine motifs. Interestingly, it has been found that SHP-2
occasionally colocalizes with FceRI (Fig. 3F), and that FceRI is
pre-associated in non-activated cells with SHP-1 [33]; these phos-
phatases exhibited enhanced enzymatic activity after FceRI trig-
gering [32]. The ﬁnding that a fraction of these phosphatases was
reversibly oxidized in their active sites [32], suggests that there
are spatiotemporal differences in enzymatic activity of the phos-
phatases. It is possible that the enzyme molecules in the vicinity
of the receptor in submembraneous region have different enzy-
matic activity immediately after receptor triggering than the rest
of molecules in the cell. Another PTP, the HePTP, also oxidized in
activated mast cells, exhibited a decreased enzymatic activity after
FceRI triggering, and could thus contribute to an enhanced phos-
phorylation in activated cells.
How could the PTPs become inactivated under physiological
conditions? Production of ROS either intracellularly [28] or by
adjacent macrophages [34] inﬂuences mast cell activation. It has
been shown that ROS produced by NADPH oxidase is crucial for
phosphorylation of many substrates [linker of activated T cells
(LAT), phospholipase (PLC)c1 and (PLC)c2], but NADPH oxidase
alone is dependent on the activity of Src family kinases and
PI3-kinase [28]. In one recent study, however, abrogation of
FceRI-dependent ROS production had no effect on degranulation
or cytokine production [29]; this would suggest that antigen-in-
duced conformational changes in FceRI and resulting impaired ac-
cess of PTPs to their substrates could be more important for
enhanced FceRI b and c subunits phosphorylation than inhibition
of enzymatic activity of the PTPs by ROS. Conformational changes
in activated MIRRs have already been described [35,36]. It is pos-
sible that a similar change could lead to a shift in PTK–PTP steady
state phosphorylation level of FceRI after mast cells triggering.
The combined data suggests, that non-activated mast cells pos-
sess preformed signaling assemblies containing immunorecep-
tors, and PTKs and PTPs which are in steady state. The binding
of a multivalent antigen could cause a change in conformation
of FceRI which would be followed by a change in the steady state
in favor of PTKs.
3. Topography of signaling molecules
Electron microscopy studies showed that most of the plasma
membrane-bound molecules are associated with osmiophilic re-
gions of the membrane [37]. Interestingly, molecules which were
expected to be localized in lipid rafts, such as non-T cell activation
linker (NTAL) and LAT, were localized individually or in small clus-
ters and were not intermixed [38]. This suggests that lipid rafts, if
they exist, are smaller than previously thought, and could be re-
stricted to individual proteins or their clusters and surrounding lip-
ids. Small size of signaling domains was documented in studies in
which FceRI dimers were capable of initiating signaling cascades
without any dramatic changes in their redistribution in the plasma
membrane [12,18]. Signalosomes of dimerized FceRI persisted at
the membrane longer than large aggregates formed by binding of
multivalent antigen to IgE–FceRI complexes. Thus, formation of
large FceRI aggregates is important for more potent removal of
the membrane signalosomes at later stages of signaling.
Interesting data were obtained in studies analyzing the topog-
raphy of membrane-bound PTPs. Antibody speciﬁc for oxidized
phosphatases reacted mostly with cytoskeleton-like structures in
non-activated mast cells [32]. Enhanced association of oxidized
phosphatases with these structures was observed in cells activatedby antigen and especially by pervanadate. The same structures
were labeled with phalloidin (Fig. 3C–E), indicating that oxidized
phosphatases are preferentially associated with actin cytoskeleton.
These data suggest that actin cytoskeleton is involved in early sig-
naling events by regulating the topography of phosphatases. Alter-
natively, actin could play a role in sequestering and/or scavenging
irreversibly oxidized PTPs. In this connection it should be men-
tioned that actin probably plays a role in sequestering Lyn kinase
to the periphery of large FceRI aggregates which are consequently
internalized [8].
Further studies showed that PTPs could also play a role in acti-
vation-induced tyrosine phosphorylation of the transmembrane
adaptor protein NTAL and LAT, which in phosphorylated state
serve as docking sites for molecules involved in FceRI signaling
[1]. Although both LAT and NTAL are detergent-resistant proteins,
they exhibited enhanced colocalization with oxidized PTPs after
FceRI triggering and even more so after treatment with pervana-
date (Fig. 4). Nevertheless, oxidized phosphatases have not been
found in DRMs [32]. Similarly, Syk was detected in FceRI clusters
on plasma membrane sheets isolated from activated mast cells
[8], in spite of the fact that only FceRI, was associated with DRMs
[39]. Moreover, experiments with disaggregated FceRI clusters
showed that the rate of their dephosphorylation was the same as
that of other proteins [39]. These data indicate that proteins in
DRMs are not protected from phosphatase activity and that even
typical DRM proteins could be phosphorylated as proposed by
the PTK–PTP interplay model.
4. Conclusions
We evaluated three models which have been proposed to ex-
plain the molecular mechanism whereby aggregation of the FceRI
initiates the ﬁrst biochemically deﬁned step in the antigen-medi-
ated signaling in mast cells – tyrosine phosphorylation of the FceRI
b subunit by Lyn kinase. Although the transphosphorylation and li-
pid raft models are supported by numerous studies that are not
limited to immunoreceptor signaling, they do not satisfactorily ex-
plain all activation events, such as tyrosine phosphorylation by
ROS. This necessitated the introduction of PTK–PTP interplay mod-
el based on an assumption that PTKs and PTPs are in steady state in
quiescent cells and activation disturbs this steady state in favor of
kinases. Considering the fact that the turnover rate of active PTPs is
100- to 1000-times higher than that of PTKs [40], one can hypoth-
esize that the PTK–PTP steady state in quiescent cell is set to over-
ride PTK, a process that could serve as a threshold of FceRI
signaling. Local ROS production or conformational changes of FceRI
leading to inactivation of the enzymatic activity of PTPs or their
inaccessibility to the substrate could precede tyrosine phosphory-
lation of the FceRI.
New approaches and methods are required to understand in de-
tail the initiation of FceRI phosphorylation and spatiotemporal
coordination of the FceRI signalosome formation. Better under-
standing of these events is expected from the introduction of
new real-timemethodologies with nanoscale resolution. Promising
are approaches analyzing immunoreceptor signaling in cell-free
systems with deﬁned composition of lipid bilayers and properly
accommodated signaling molecules. Genetic approaches will no
doubt play a major role in deciphering signaling events in a com-
plex cellular environment. Detailed analysis of properties of cells
with knock-out of selected genes and restored with various mutant
forms of the gene (knock-in approach) could still lead to the dis-
covery of new players involved in initial stages of FceRI signaling.
These, in turn, could become targets for new drugs, and thus con-
tribute to new rational approaches to therapy of mast cell medi-
ated diseases.
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